# US 2023/0144845 A1 · Alpha-Ketobutyrate, 2-Hydroxybutyrate, and Alpha-Ketoglutarate for Stimulating Hair Growth

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0144845 A1
- Document ID: US20230144845A1
- Status: Published application
- Kind: A1
- Application number: 18/154,498
- Filed: 2023-01-13
- Published: 2023-05-11
- Earliest claimed: 2016-09-30
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Jing Huang; Min Chai; Meisheng Jiang; Xudong Fu; Heejun Hwang
- Web page: https://patentgrep.com/patent/US20230144845A1

## CPC

- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0017: {Non-human animal skin, e.g. pour-on, spot-on}
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61Q 7/00: Preparations for affecting hair growth
- A61Q 19/02: for chemically bleaching or whitening the skin
- A61Q 19/04: for chemically tanning the skin (topical sun or radiation screening or tanning preparations A61Q17/04)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Disclosed herein are methods and compositions for treating, inhibiting, or reducing hair loss, treating, inhibiting, or reducing pigmentation loss, improving or stimulating hair growth, and/or improving or stimulating pigmentation production in a subject with one or more alpha-ketobutyrate compounds and/or one or more glutarate compounds.

## Claims

### Claim 1

A method for treating, inhibiting, or reducing hair loss; improving or stimulating hair growth; treating, inhibiting, or reducing pigmentation loss; and/or improving or stimulating pigmentation production in a subject which comprises administering to the subject a therapeutically effective amount of one or more alpha-ketobutyrate compounds and/or one or more glutarate compounds.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the one or more alpha-ketobutyrate compounds is alpha-ketobutyrate (α-KB), the one or more glutarate compounds is alpha-ketoglutarate (α-KG), and/or the one or more glutarate compounds is 2-hydroxypentanedioate (2-HG).

### Claim 3

A method of stimulating new hair growth in a subject in need thereof, comprising:
administering to the subject a composition comprising a therapeutically effective amount of a compound of Formula I:
wherein
R1 is hydrogen, halogen, —CHO, —OR7, —NR8R9, —COOR7, —CONR8R9, —SR10, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl;
R2 and R3 are each independently hydrogen, halogen, —CN, —CHO, —OR7, —NR8R9, —COOR7, —CONR8R9, —NO2, —SR10, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; or R2 and R3, together with the atom to which they are bound, form an oxo;
R4, R5, and R6 are each independently hydrogen, halogen, —CN, —CHO, —OR7, —NR8R9, —COOR7, —CONR8R9, —NO2, —SR10, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; and
R7, R8, R9, and R10 are each independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; or a salt thereof; and
an excipient; and
wherein the composition is administered to an area on the subject absent of hair to stimulate new hair growth.

### Claim 4

A composition comprising a compound of Formula I:
wherein
R1 is hydrogen, halogen, —CHO, —OR7, —NR8R9, —COOR7, —CONR8R9, —SR10, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl;
R2 and R3 are each independently hydrogen, halogen, —CN, —CHO, —OR7, —NR8R9, —COOR7, —CONR8R9, —NO2, —SR10, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; or R2 and R3, together with the atom to which they are bound, form an oxo;
R4, R5, and R6 are each independently hydrogen, halogen, —CN, —CHO, —OR7, —NR8R9, —COOR7, —CONR8R9, —NO2, —SR10, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; and
R7, R8, R9, and R10 are each independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; or a salt thereof,
and a pharmaceutically acceptable excipient and/or a tissue penetrating enhancer.

### Claim 5 (depends on 3, 4)

The method of claim 3 or the composition according to claim 4, wherein R1 is
(a) hydrogen, —CHO, or —OR7;
(b) —OR7, wherein R7 is hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl; or
(c) —OR7, wherein R7 is C1-20 substituted or unsubstituted alkyl.

### Claim 6 (depends on 3, 4, 5)

The method of claim 3, the composition according to claim 4, or the method or composition of claim 5, wherein
(a) R2 is hydrogen, halogen, —CN, —CHO, or —NR8R9, wherein R8 and R9 are each independently hydrogen or substituted or unsubstituted alkyl; or
(b) R2 and R3, together with the atom to which they are bound, form an oxo.

### Claim 7 (depends on 3, 4, 5, 6)

The method of claim 3, the composition according to claim 4, or the method or composition of claim 5 or claim 6, wherein R4, R5, and R6 are each independently hydrogen, —CHO, —OR7, —NR8R9, —COOR7, or —CONR8R9, wherein R7, R8, and R9 are each independently hydrogen or C1-20 substituted or unsubstituted alkyl.

### Claim 8 (depends on 3, 4, 5, 6, 7)

The method of claim 3, the composition according to claim 4, or the method or composition of any one of claims 5 to 7, wherein R4 is —COOR7 or —CONR8R9, wherein R7, R8, and R9 are each independently hydrogen or C1-20 substituted or unsubstituted alkyl.

### Claim 9 (depends on 3, 4, 5, 6, 7, 8)

The method of claim 3, the composition according to claim 4, or the method or composition of any one of claims 5 to 8, wherein the compound of Formula I is alpha-ketoglutarate (α-KG), 2-HB, or alpha-ketobutyrate (α-KB).

### Claim 10 (depends on 3, 4, 5, 6, 7, 8, 9)

The method of claim 3, the composition according to claim 4, or the method or composition of any one of claims 5 to 9, wherein the concentration of the compound of Formula I in the composition is at least 1 mM, 2 mM, 3 mM, 4 mM, 5 mM, 6 mM, 7 mM, 8 mM, 9 mM, 10 mM, 11 mM, 12 mM, 13 mM, 14 mM, 15 mM, 16 mM, 17 mM, 18 mM, 19 mM, 20 mM, 25 mM, 30 mM, 35 mM, 40 mM, 45 mM, or 50 mM.

### Claim 11 (depends on 3, 4, 5, 6, 7, 8, 9, 10)

The method of claim 3, the composition according to claim 4, or the method or composition of any one of claims 5 to 10, wherein the composition is formulated for oral, parenteral, or topical administration.

### Claim 12 (depends on 3, 4, 5, 6, 7, 8, 9, 10)

The method of claim 3, the composition according to claim 4, or the method or composition of any one of claims 5 to 10, wherein the composition is formulated as a gel, a cream, an ointment, a paste, or a lotion.

### Claim 13 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of claim 3, the composition according to claim 4, or the method or composition of any one of claims 5 to 12, wherein the composition further comprises one or more growth factors, such as TGF-β2, IGF-1, KGF, and HGF.

### Claim 14 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of claim 3, the composition according to claim 4, or the method or composition of any one of claims 5 to 13, the composition is capable of stimulating a cell to enter into anagen phase when contacted therewith.

### Claim 15 (depends on 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The method of any one of claims 3 and 5 to 14, wherein the area is absent of hair due to a disease or condition that decreases or inhibits hair growth, an injury, chemotherapy and/or radiation therapy, or surgery.

### Claim 16 (depends on 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 3 and 5 to 15, wherein the subject has a thyroid disorder, a pituitary gland disorder, alopecia areata, anagen effluvium, and/or telogen effluvium.

### Claim 17 (depends on 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 3 and 5 to 15, wherein the number of hair follicles in the subject after administration of the composition is higher relative to the number of hair follicles in the subject prior to administration of the composition.

### Claim 18 (depends on 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 3 and 5 to 15, wherein the weight of a hair in the subject after administration of the composition is greater relative to the weight of a hair in the subject prior to administration of the composition.

### Claim 19 (depends on 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 3 and 5 to 15, wherein the hair shaft length of a hair in the subject is increased faster after administration of the composition relative to the hair shaft length of a hair in the subject prior to administration of the composition.

### Claim 20 (depends on 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 3 and 5 to 15, wherein the growth rate of a hair in the subject is increased after administration of the composition relative to the growth rate of a hair in the subject prior to administration of the composition.
